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worldwide health and economic burden. The propensity towards
developing into chronic, disabling conditions drives the rise in health
and economic costs associated with treatment, productivity loss and
compulsory third party insurance claims. Current treatments fail to
address the well-documented heterogeneity of WAD and often result
in poor outcomes. A novel approach is to evaluate whether the care
provided according to the estimated risk of poor prognosis improves
health outcomes while remaining cost-effective. Research questions:
(1) Does a guideline-based clinical pathway of care improve health
outcomes after whiplash injury compared to usual care? (2) Does risk
of recovery have a differential effect on health outcomes for the
clinical pathway of care? (3) Is the clinical pathway of care
intervention cost-effective? (4)What are the variations in professional
practice between usual care and the clinical pathway of care? Design:
Multi-centre, randomised, controlled trial conducted over two
Australian states: Queensland and New South Wales. Participants
and [26_TD$DIFF]setting: 236 people with WAD (grade I-III, within 6 weeks of
injury) and their primary healthcare providers. Intervention: A
clinical pathway of care, with care matched to the predicted risk of
poor recovery. Participants at low risk of ongoing pain and disability
(hence, predicted to fully recover) will receive up to three sessions of
guideline-based advice and exercise with their primary healthcare
provider. Participants at medium/high risk of developing ongoing pain
and disability will be referred to a specialist (deﬁned as a practitioner
with expertise in whiplash) who will conduct a more in-depth
physical and psychological assessment. As a result, the specialist will
liaisewith the original primary healthcare provider and determine one
of three further pathways of care. Control: Usual care provided by the
primary healthcare provider that is based on clinical judgment.
Measurements: Primary (global rating of change and neck-related
disability) and secondary (self-efﬁcacy, pain intensity, general health
and disability and psychological health) outcomes will be collected
using validated scales. Direct (eg, professional care, transportation
costs, time spent for care, co-payments) and indirect (eg, lost economic
productivity) costs will be obtained through an electronic cost diary.
Health and cost outcomes will be assessed at baseline, 3, 6 and
12 months after randomisation. Professional practice outcomes will be
evaluated through questionnaires completed by healthcare providers
and their patients at 3 months. Procedure: Potential participants
(patients) will be identiﬁed through emergency departments, primary
health clinics and advertisements. Eligible participants will completehttp://dx.doi.org/10.1016/j.jphys.2016.02.006
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creativecommons.org/licenses/by-nc-nd/4.0/).baseline assessments and will be categorised into low or medium/high
risk of poor recovery using a clinical prediction rule. After this
assessment, participants will be randomly allocated to either a control
group (n = 118) or intervention group (n = 118), stratiﬁed by risk
subgroup and treatment site. The participants’ nominated primary
healthcare providers will be informed of their involvement in the trial.
Consent will be obtained from the primary healthcare providers to
participate and to obtain information about professional practice.
Participants in the intervention group will additionally have access to
an interactive website that provides information about whiplash and
recovery relative to their risk category. Analysis: Analysis will be
conducted on an intention-to-treat basis. Outcomes will be analysed
independently through cross-sectional analyses using generalised
linear models methods, with an appropriate link function, to test for
an intervention effect, adjusted for the baseline values. The risk
category will be tested for its association with treatment effect by
adding risk group to the regression equation. Cost-effectiveness will be
calculated using utility weights and the resulting measure will be cost
per quality-adjusted life year (QALY) saved. Professional practice
outcomeswill be analysed using descriptive statistics.Discussion: [11_TD$DIFF] his
research is signiﬁcant as it will be the ﬁrst study to address the
heterogeneity of whiplash by implementing a clinical pathway of care
that matches evidence-based interventions to projected risk of poor
recovery. The results of this trial have the potential to change clinical
practice for WAD, thereby maximising treatment effects, improving
patient outcomes, reducing costs andmaintaining the compulsory third
party system.
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